Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold, Silver & Bullion  :  Gold futures finish near four-month high on Thursday

01-Feb2019

Gold futures finish near four-month high on Thursday

Gold futures finished near four-month high level on Thursday, owing to weakness in US currency amid Federal Reserve's stance to keep the interest rates unchanged. Moreover, safe heaven investments in midst of geopolitical tensions also buoyed the yellow metal.

Gold futures for February delivery settled up 0.7 percent to $1,319.70 on the Comex division of the New York Mercantile. Spot gold was unchanged at $1,320.01 per ounce.


Related News

View all news

Gold futures end higher on Tuesday

Gold futures finished higher on Tuesday, marking biggest single-session percentage rise since November, as investors increased bullion investments amid potential progress on Brexit and trade talks between......

Gold futures finish near two week high on Friday

Gold futures finished near two week high on Friday, as speculators eyed that Federal Reserve would hold pat on monetary tightening, followed by the weaker than expected US economic data. Moreover, progress......

Gold futures end slightly lower on Thursday

Gold futures ended slightly lower on Thursday, as dollar index marked gain for the week amid US-China trade talks. However, weaker than expected economic data from the United States trimmed the......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......